Sign Up Now to Download a Free Research Report on
Sign-Up to Get the Equity Report on this Company Plus Exclusive Access to Our Winning Newsletter Alerts
Having problems viewing PDF files? Vical, Inc.
Vical shares spiked 15.43 percent on over four times the average daily volume Wednesday to close at $4.04 a share. The company researches and develops biopharmaceutical products based on its patented DNA delivery technologies for the prevention and treatment of serious or life-threatening diseases. Vical had cash and investments of approximately $86 million at year-end 2012.
Going forward ... (see research report)
Subscribe to News Feeds